{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T21:51:16Z","timestamp":1726005076372},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,3,8]],"date-time":"2009-03-08T00:00:00Z","timestamp":1236470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s11936-009-0011-y","type":"journal-article","created":{"date-parts":[[2009,3,7]],"date-time":"2009-03-07T04:40:37Z","timestamp":1236400837000},"page":"104-113","source":"Crossref","is-referenced-by-count":5,"title":["Venous thromboembolism in pregnancy"],"prefix":"10.1007","volume":"11","author":[{"given":"Marcelo P.","family":"Villa-Forte Gomes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,8]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9378(65)90308-X","volume":"93","author":"U. Villasanta","year":"1965","unstructured":"Villasanta U: Thromboembolic disease in pregnancy. Am J Obstet Gynecol 1965, 93:142\u2013160.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/003693309604100305","volume":"41","author":"N.S. Macklon","year":"1996","unstructured":"Macklon NS, Greer IA: Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J 1996, 41:83\u201386.","journal-title":"Scott Med J"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","volume":"194","author":"A.H. James","year":"2006","unstructured":"James AH, Jamison MG, Brancazio LR, et al.: Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006, 194:1311\u20131315.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR4","first-page":"1183","volume":"8","author":"M. McColl","year":"1997","unstructured":"McColl M, Ramsay JE, Tait RC, et al.: Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997, 8:1183\u20131188.","journal-title":"Thromb Haemost"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1479-828X.2007.00799.x","volume":"48","author":"S. Sharma","year":"2008","unstructured":"Sharma S, Monga D: Venous thromboembolism during pregnancy and the postpartum period: incidence and risk factors in a large Victorian health service. Aust N Z J Obstet Gynaecol 2008, 48:44\u201349.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ajog.2007.08.041","volume":"198","author":"A.F. Jacobsen","year":"2008","unstructured":"Jacobsen AF, Skjeldestad FE, Sandset PM: Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium: a register-based case-control study. Am J Obstet Gynecol 2008, 198:233\u2013237.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0038-1648485","volume":"67","author":"J.S. Ginsberg","year":"1992","unstructured":"Ginsberg JS, Brill-Edwards P, Burrows RF, et al.: Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost 1992, 67:519\u2013520.","journal-title":"Thromb Haemost"},{"key":"11_CR8","first-page":"56","volume":"108","author":"E.L. Simpson","year":"2001","unstructured":"Simpson EL, Lawrenson RA, Nightingale AL, et al.: Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. Br J Obstet Gynaecol 2001, 108:56\u201360.","journal-title":"Br J Obstet Gynaecol"},{"key":"11_CR9","first-page":"1","volume":"52","author":"J. Chang","year":"2003","unstructured":"Chang J, Elam-Evans LD, Berg CJ, et al.: Pregnancy-related mortality surveillance: United States, 1991-1999. MMWR Surveill Summ 2003, 52:1\u20138.","journal-title":"MMWR Surveill Summ"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","volume":"132","author":"L. Robertson","year":"2005","unstructured":"Robertson L, Wu O, Langhorne P, et al.: Thrombophilia in pregnancy: a systematic review. Br J Haematol 2005, 132:171\u2013196.","journal-title":"Br J Haematol"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMra0707993","volume":"359","author":"P.E. Marik","year":"2008","unstructured":"Marik PE, Plante LA: Venous thromboembolism during pregnancy. N Engl J Med 2008, 359:2025\u20132033.","journal-title":"N Engl J Med"},{"key":"11_CR12","unstructured":"Greer IA, Thomson AJ, on behalf of the Guidelines and Audit Committee of the Royal College of Obstetricians and Gynaecologists: Thromboembolic disease in pregnancy and the puerperium: acute management. Green-top Guideline No. 28. London, February 2007. Available at http\/\/www.rcog.org.uk\/resources\/Public\/pdf\/green_top_28_thromboembolic_minorrevision.pdf. Accessed November 13, 2008."},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajog.2004.11.037","volume":"193","author":"A.H. James","year":"2005","unstructured":"James AH, Tapson VF, Goldhaber SZ: Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol 2005, 193:216\u2013219.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.AOG.0000233154.62729.24","volume":"108","author":"C. Deneaux-Tharaux","year":"2006","unstructured":"Deneaux-Tharaux C, Carmona E, Bowvier-Colle M-H, et al.: Postpartum maternal mortality and cesarean delivery. Obstet Gynecol 2006, 108:541\u2013548.","journal-title":"Obstet Gynecol"},{"issue":"6Suppl","key":"11_CR15","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","volume":"133","author":"S.M. Bates","year":"2008","unstructured":"Bates SM, Greer IA, Pabinger I, et al.: Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. American College of Chest Guidelines Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(6 Suppl):844S\u2013886S.","journal-title":"Chest"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","volume":"16","author":"K.A. Bremme","year":"2003","unstructured":"Bremme KA: Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003, 16:153\u2013168.","journal-title":"Best Pract Res Clin Haematol"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0002-9378(72)90559-5","volume":"113","author":"T. Rosenthal","year":"1972","unstructured":"Rosenthal T, Shani M, Deutsch V, et al.: The Budd-Chiari syndrome after pregnancy. Report of two cases and a review of the literature. Am J Obstet Gynecol 1972, 113:789\u2013792.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1191\/1358863x03vm461ra","volume":"8","author":"S.R. Deitcher","year":"2003","unstructured":"Deitcher SR, Gomes MPV: Hypercoagulable state testing and malignancy screening following venous thromboembolic events. Vasc Med 2003, 8:33\u201346.","journal-title":"Vasc Med"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","volume":"143","author":"J.A. Heit","year":"2005","unstructured":"Heit JA, Kobbervig CE, James AH, et al.: Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005, 143:697\u2013706.","journal-title":"Ann Intern Med"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200002103420602","volume":"342","author":"A. Gerhardt","year":"2000","unstructured":"Gerhardt A, Scharf RE, Beckman MW, et al.: Prothrombin and factor V mutations in women with thrombosis during pregnancy and the puerperium. N Engl J Med 2000, 342:374\u2013380.","journal-title":"N Engl J Med"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006254-199904000-00023","volume":"54","author":"J.G. Ray","year":"1999","unstructured":"Ray JG, Chan WS: Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999, 54:265\u2013271.","journal-title":"Obstet Gynecol Surv"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1160\/TH06-11-0650","volume":"97","author":"A. Blanco-Molina","year":"2007","unstructured":"Blanco-Molina A, Trujillo-Santos J, Criado J, et al.: Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost 2007, 97:186\u2013190.","journal-title":"Thromb Haemost"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/s-0037-1613085","volume":"87","author":"I. Martinelli","year":"2002","unstructured":"Martinelli I, De Stefano V, Taioli E, et al.: Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost 2002, 87:791\u2013795.","journal-title":"Thromb Haemost"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/00016340802108763","volume":"87","author":"N. Pallasmaa","year":"2008","unstructured":"Pallasmaa N, Ekblad U, Gissler M: Severe maternal morbidity and the mode of delivery. Acta Obstet Gynecol Scand 2008, 87:662\u2013668.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ajog.2005.07.044","volume":"194","author":"M.A. Rodger","year":"2006","unstructured":"Rodger MA, Avruch LI, Howley HE, et al.: Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section. Am J Obstet Gynecol 2006, 194:436\u2013437.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"56.e1","DOI":"10.1016\/j.ajog.2007.06.004","volume":"198","author":"C. Holmgren","year":"2008","unstructured":"Holmgren C, Aagaard-Tillery KM, Silver RM, et al.: Hyperemesis in pregnancy; an evaluation of treatment strategies with maternal and neonatal outcomes. Am J Obstet Gynecol 2008, 198:56.e1\u201356.e4.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR27","first-page":"149","volume":"32","author":"A. Mancuso","year":"2005","unstructured":"Mancuso A, De Vivo A, Fanara G, et al.: Upper body venous thrombosis associated with ovarian stimulation: case report and review of the literature. Clin Exp Obstet Gynecol 2005, 32:149\u2013154.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.thromres.2007.05.023","volume":"121","author":"W.S. Chan","year":"2008","unstructured":"Chan WS, Dixon ME: The \u201cART\u201d of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res 2008, 121:713\u2013726.","journal-title":"Thromb Res"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","volume":"114","author":"B. Brenner","year":"2004","unstructured":"Brenner B: Haemostatic changes in pregnancy. Thromb Res 2004, 114:409\u2013414.","journal-title":"Thromb Res"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1471-0528.1997.tb11044.x","volume":"104","author":"N.S. Macklon","year":"1997","unstructured":"Macklon NS, Greer IA: The deep venous system in the puerperium: an ultrasound study. Br J Obstet Gynaecol 1997, 104:198\u2013200.","journal-title":"Br J Obstet Gynaecol"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH06-02-0086","volume":"96","author":"C. Biron-Andreani","year":"2006","unstructured":"Biron-Andreani C, Schved J-F, Daures J-P: Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis. Thromb Haemost 2006, 96:14\u201318.","journal-title":"Thromb Haemost"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1001\/archinte.164.17.1932","volume":"164","author":"I. Bank","year":"2004","unstructured":"Bank I, Libourel EJ, Middeldorp S, et al.: Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med 2004, 164:1932\u20131937.","journal-title":"Arch Intern Med"},{"key":"11_CR33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2141.2001.02766.x","volume":"113","author":"S. Middeldorp","year":"2001","unstructured":"Middeldorp S, Libourel EJ, Hamuly\u00e1k K, et al.: The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. Br J Haematol 2001, 113:553\u2013555.","journal-title":"Br J Haematol"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2003-37947","volume":"20","author":"D. Ogunyemi","year":"2003","unstructured":"Ogunyemi D, Cuellar F, Ku W et al.: Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy. Am J Perinatol 2003, 20:17\u201324.","journal-title":"Am J Perinatol"},{"key":"11_CR35","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685","volume":"86","author":"J.S. Ginsberg","year":"1995","unstructured":"Ginsberg JS, Wells PS, Brill-Edwards P, et al.: Antiphospholipid antibodies and venous thromboembolism. Blood 1995, 86:3685\u20133691.","journal-title":"Blood"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","volume":"41","author":"D. Erkan","year":"2002","unstructured":"Erkan D, Yazici Y, Peterson MG, et al.: A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 2002, 41:924\u2013929.","journal-title":"Rheumatology (Oxford)"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0037-1613602","volume":"90","author":"A. Gerhardt","year":"2003","unstructured":"Gerhardt A, Scharf RE, Zotz RB: Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb Haemost 2003, 90:77\u201385.","journal-title":"Thromb Haemost"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1614442","volume":"81","author":"P. Simioni","year":"1999","unstructured":"Simioni P, Sanson BJ, Prandoni P, et al.: Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999, 81:198\u2013202.","journal-title":"Thromb Haemost"},{"key":"11_CR39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.AOG.0000173986.32528.ca","volume":"106","author":"D. Dizon-Townson","year":"2005","unstructured":"Dizon-Townson D, Miller C, Sibai B, et al.: The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005, 106:517\u2013524.","journal-title":"Obstet Gynecol"},{"key":"11_CR40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1055\/s-0037-1616134","volume":"86","author":"I. Martinelli","year":"2001","unstructured":"Martinelli I, Legnami C, Bucciarelli P, et al.: Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001, 86:800\u2013803.","journal-title":"Thromb Haemost"},{"key":"11_CR41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2141.2003.04582.x","volume":"123","author":"M.M. Samama","year":"2003","unstructured":"Samama MM, Rached RA, Horellou MH, et al.: Pregnancyassociated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone. Br J Haematol 2003, 123:327\u2013334.","journal-title":"Br J Haematol"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1538-7836.2007.02880.x","volume":"6","author":"I. Martinelli","year":"2008","unstructured":"Martinelli I, Battaglioli T, De Stefano V, et al.: The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A. J Thromb Haemost 2008, 6:494\u2013498.","journal-title":"J Thromb Haemost"},{"key":"11_CR43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-125-12-199612150-00003","volume":"125","author":"P.W. Friedrich","year":"1996","unstructured":"Friedrich PW, Sanson BJ, Simioni P, et al.: Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med 1996, 125:955\u2013960.","journal-title":"Ann Intern Med"},{"key":"11_CR44","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood.V94.8.2590.420k40_2590_2594","volume":"94","author":"H.H. Boven Van","year":"1999","unstructured":"Van Boven HH, Vandenbroucke JP, Bri\u00ebt E, et al.: Genegene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency. Blood 1999, 94:2590\u20132594.","journal-title":"Blood"},{"key":"11_CR45","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","volume":"100","author":"I. Pabinger","year":"2002","unstructured":"Pabinger I, Grafenhofer H, Kyrle PA, et al.: Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood 2002, 100:1060\u20131062.","journal-title":"Blood"},{"key":"11_CR46","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","volume":"343","author":"P. Brill-Edwards","year":"2000","unstructured":"Brill-Edwards P, Ginsberg JS, Gent M, et al.: Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med 2000, 343:1439\u20131444.","journal-title":"N Engl J Med"},{"key":"11_CR47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","volume":"3","author":"I. Pabinger","year":"2005","unstructured":"Pabinger I, Grafenhofer H, Kaider A, et al.: Risk of pregnancyassociated venous thromboembolism in women with a history of venous thromboembolism. J Thromb Haemost 2005, 3:949\u2013954.","journal-title":"J Thromb Haemost"},{"key":"11_CR48","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2006.06317.x","volume":"135","author":"V. Stefano De","year":"2006","unstructured":"De Stefano V, Martinelli I, Rossi E, et al.: The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol 2006, 135:386\u2013391.","journal-title":"Br J Haematol"},{"key":"11_CR49","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/archinte.1989.00390100059015","volume":"149","author":"J.S. Ginsberg","year":"1989","unstructured":"Ginsberg JS, Kowalchuk G, Hirsh J, et al.: Heparin therapy during pregnancy: risks to the fetus and mother. Arch Intern Med 1989, 149:2233\u20132236.","journal-title":"Arch Intern Med"},{"key":"11_CR50","first-page":"1134","volume":"108","author":"J. Lepercq","year":"2001","unstructured":"Lepercq J, Conard J, Borel-Derlon A, et al.: Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. Br J Obstet Gynaecol 2001, 108:1134\u20131140.","journal-title":"Br J Obstet Gynaecol"},{"key":"11_CR51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1160\/TH06-02-0108","volume":"95","author":"C. Schaefer","year":"2006","unstructured":"Schaefer C, Hannemann D, Meister R, et al.: Vitamin K antagonists and pregnancy outcome: a multi-centre prospective study. Thromb Haemost 2006, 95:949\u2013957.","journal-title":"Thromb Haemost"},{"key":"11_CR52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","volume":"160","author":"W.S. Chan","year":"2000","unstructured":"Chan WS, Anand S, Ginsberg JS: Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000, 160:191\u2013196.","journal-title":"Arch Intern Med"},{"key":"11_CR53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1055\/s-0037-1615641","volume":"85","author":"J. Wesseling","year":"2001","unstructured":"Wesseling J, van Driel D, Heymans HAS, et al.: Coumarins during pregnancy: long term effects on growth and development in school age children. Thromb Haemost 2001, 85:609\u2013613.","journal-title":"Thromb Haemost"},{"key":"11_CR54","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJM200404293501825","volume":"350","author":"C.E. Dempfle","year":"2004","unstructured":"Dempfle CE: Minor transplacental passage of fondaparinux in vivo. N Engl J Med 2004, 350:1914\u20131915.","journal-title":"N Engl J Med"},{"key":"11_CR55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.thromres.2006.03.008","volume":"119","author":"J. Harenberg","year":"2007","unstructured":"Harenberg J. Treatment of a woman with lupus and thromboembolism and cutaneous intolerance of heparins using fondaparinux during pregnancy. Thromb Res 2007, 119:385\u2013388.","journal-title":"Thromb Res"},{"key":"11_CR56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.mbc.0000214710.19116.40","volume":"17","author":"A. Wijesiriwardana","year":"2006","unstructured":"Wijesiriwardana A, Lees DA, Lush C: Fondaparinux as anticoagulant in a pregnant woman with heparin allergy. Blood Coagul Fibrinolysis 2006, 17:147\u2013149.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"11_CR57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2002-35284","volume":"28","author":"E. Lindhoff-Last","year":"2002","unstructured":"Lindhoff-Last E, Bauersachs R: Heparin-induced thrombocytopenia: alternative anticoagulation in pregnancy and lactation. Semin Thromb Hemost 2002, 28:439\u2013445.","journal-title":"Semin Thromb Hemost"},{"key":"11_CR58","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.0306-5251.2001.01517.x","volume":"52","author":"C. Richter","year":"2001","unstructured":"Richter C, Sitzmann J, Lang P, et al.: Excretion of lowmolecular-weight heparin in human milk. Br J Clin Pharmacol 2001, 52:708\u2013710.","journal-title":"Br J Clin Pharmacol"},{"key":"11_CR59","first-page":"254","volume":"70","author":"T.C. Dahlman","year":"1993","unstructured":"Dahlman TC: Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993, 70:254\u2013257.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0950-3552(97)80024-7","volume":"11","author":"C. Nelson-Piercy","year":"1997","unstructured":"Nelson-Piercy C: Hazards of heparin: allergy, heparininduced thrombocytopenia and osteoporosis. Baillieres Clin Obstet Gynaecol 1997, 11:489\u2013509.","journal-title":"Baillieres Clin Obstet Gynaecol"},{"issue":"6Suppl","key":"11_CR61","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","volume":"133","author":"T.E. Warkentin","year":"2008","unstructured":"Warkentin TE, Greinacher A, Koster A, et al.: Treatment and prevention of heparin-induced thrombocytopenia. Chest 2008, 133(6 Suppl):340S\u2013380S.","journal-title":"Chest"},{"key":"11_CR62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","volume":"106","author":"I.A. Greer","year":"2005","unstructured":"Greer IA, Nelson-Piercy C: Low-molecular-weight heparins for thrombophrophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005, 106:401\u2013407.","journal-title":"Blood"},{"key":"11_CR63","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.AOG.0000178792.51401.3a","volume":"106","author":"J.N. Qui\u00f1ones","year":"2005","unstructured":"Qui\u00f1ones JN, James DN, Stamilio DM, et al.: Thrombophrophylaxis after cesarean delivery: a decision analysis. Obstet Gynecol 2005, 106:733\u2013740.","journal-title":"Obstet Gynecol"},{"issue":"2Pt1","key":"11_CR64","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/AOG.0b013e31817e8acc","volume":"112","author":"M.A. Rodger","year":"2008","unstructured":"Rodger MA, Paidas M, McLintock C, et al.: Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008, 112(2 Pt 1):320\u2013324.","journal-title":"Obstet Gynecol"},{"key":"11_CR65","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/oxfordjournals.humrep.a135907","volume":"10","author":"R.S. Rai","year":"1995","unstructured":"Rai RS, Clifford K, Cohen H, et al.: High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995, 10:3301\u20133304.","journal-title":"Hum Reprod"},{"key":"11_CR66","doi-asserted-by":"crossref","unstructured":"Empson M, Lassere M, Craig J, et al.: Prevention of miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005, CD002859.","DOI":"10.1002\/14651858.CD002859.pub2"},{"key":"11_CR67","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","volume":"83","author":"L.S. Noble","year":"2005","unstructured":"Noble LS, Kutteh WH, Lashey N, et al.: Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 2005, 83:684\u2013690.","journal-title":"Fertil Steril"},{"key":"11_CR68","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","volume":"26","author":"M.D. Stephenson","year":"2004","unstructured":"Stephenson MD, Ballem PJ, Tsang P, et al.: Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 2004, 26:729\u2013734.","journal-title":"J Obstet Gynaecol Can"},{"key":"11_CR69","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archinte.162.11.1221","volume":"162","author":"G.S. Ahearn","year":"2002","unstructured":"Ahearn GS, Hadjiliadis D, Govert JA, Tapson VS: Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case-report and review of the literature. Arch Intern Med 2002, 162:1221\u20131227.","journal-title":"Arch Intern Med"},{"issue":"10Suppl","key":"11_CR70","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1097\/01.CCM.0000183157.15533.4C","volume":"33","author":"S.E. Stone","year":"2005","unstructured":"Stone SE, Morris TA: Pulmonary embolism during and after pregnancy. Crit Care Med 2005, 33(10 Suppl):S294\u2013S300.","journal-title":"Crit Care Med"},{"key":"11_CR71","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1471-0528.2008.01704.x","volume":"115","author":"S. Gupta","year":"2008","unstructured":"Gupta S, Ettles DF, Robinson GJ, et al.: Inferior vena cava filter use in pregnancy: preliminary experience. Br J Obstet Gynaecol 2008, 115:785\u2013788.","journal-title":"Br J Obstet Gynaecol"},{"key":"11_CR72","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jvs.2005.01.023","volume":"41","author":"K. Kawamata","year":"2005","unstructured":"Kawamata K, Chiba Y, Tanaka R, et al.: Experience of temporary inferior vena cava filters inserted in the perinatal period to prevent pulmonary embolism in pregnant women with deep vein thrombosis. J Vasc Surg 2005, 41:652\u2013656.","journal-title":"J Vasc Surg"},{"key":"11_CR73","first-page":"172","volume":"28","author":"T.T. Horlocker","year":"2003","unstructured":"Horlocker TT, Wedel DJ, Benzon H, et al.: Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003, 28:172\u2013197.","journal-title":"Reg Anesth Pain Med"},{"key":"11_CR74","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.thromres.2003.09.013","volume":"111","author":"V.M. Ulander","year":"2003","unstructured":"Ulander VM, Lehtola A, Kaaja R: Long-term outcome of deep venous thrombosis during pregnancy treated with unfractionated heparin or low molecular weight heparin. Thromb Res 2003, 111:239\u2013242.","journal-title":"Thromb Res"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-009-0011-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-009-0011-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-009-0011-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:57:10Z","timestamp":1589633830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-009-0011-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,8]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11936-009-0011-y","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,8]]}}}